Contact this trialFirst, we need to learn more about you.
Alkylating agents
Combination Chemotherapy + TTF for Pancreatic Cancer
Recruiting1 awardPhase 1 & 2
Jacksonville, Florida
This trial tests a new treatment for advanced pancreatic cancer using a mix of three chemotherapy drugs and a special device that uses electric fields to target cancer cells. Patients continue with one drug and the electric field device. The goal is to find a more effective front-line therapy for patients whose cancer has spread. The use of electric fields to disrupt cancer cell division is a novel approach that has shown promise in other cancers, such as malignant pleural mesothelioma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service